Furthermore, increased iRhom2 expression correlated with poor survival (P < 0.0005), but did not correlate with any other clinicopathological indicators of prognosis, such as extracapsular spread or tumour size, suggesting that it may be an independent prognostic indicator. The gene discussed is RHBDF2; the disease is neoplasm.